Novo Nordisk Shares Sink After Sales Outlook Misses As US GLP-1 Competition Intensifies
Novo Nordisk Shares Sink After Sales Outlook Misses As US GLP-1 Competition Intensifies Novo Nordisk ADRs were clubbed like a baby seal around midday after the Danish drugmaker said in an early full-year outlook release that it expects sales to shrink 5% to 13% at constant exchange rates, far worse than the expected 1.3% decline […]
Novo Nordisk Shares Sink After Sales Outlook Misses As US GLP-1 Competition Intensifies Read More »









